Fluicell
10.50 SEK
-7.89 %
Less than 1K followers
FLUI
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-7.89 %
-19.23 %
-29.53 %
+2.94 %
-26.83 %
-25.00 %
-93.90 %
-99.09 %
-99.05 %
Fluicell operates in biotechnology. The company conducts research and development in the processing of cell composition in the development of new drugs. The company has developed a product portfolio consisting of patented research instruments, which are used to study, analyze and ultimately process cells. In addition, there is expertise in 2D/3D printing. Fluicell was founded in 2012 and is headquartered in Gothenburg.
Read moreMarket cap
14.42M SEK
Turnover
47.26K SEK
Revenue
1.86M
EBIT %
-851.61 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
20/2
2026
Annual report '25
8/5
2026
Interim report Q1'26
14/5
2026
General meeting '26
All
Press releases
3rd party
ShowingAll content types
Fluicell offentliggör delårsrapport för det tredje kvartalet och de första nio månaderna av 2025
Fluicell tillkännager lönsamhets- och kassaflödesprognos för 2026
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools